Found: 152
Select item for more details and to access through your institution.
Direct and Indirect Effect of Guselkumab on Anxiety, Depression, and Quality of Life in Patients with Moderate-to-Severe Plaque Psoriasis: A Mediation Analysis.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 9, p. 2577, doi. 10.1007/s13555-024-01250-9
- By:
- Publication type:
- Article
Practical Recommendations on Laboratory Monitoring in Patients with Atopic Dermatitis on Oral JAK Inhibitors.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 9, p. 2653, doi. 10.1007/s13555-024-01243-8
- By:
- Publication type:
- Article
Long-Term Safety of Risankizumab in Patients with Psoriatic Disease: A Comprehensive Analysis from Clinical Trials.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 9, p. 2523, doi. 10.1007/s13555-024-01238-5
- By:
- Publication type:
- Article
Effectiveness and safety of secukinumab updosing in patients with moderate to severe plaque psoriasis: data from the PURE registry.
- Published in:
- Archives of Dermatological Research, 2024, v. 316, n. 7, p. 1, doi. 10.1007/s00403-024-03122-w
- By:
- Publication type:
- Article
Safety of Janus kinase (JAK) inhibitors in the short‐term treatment of atopic dermatitis.
- Published in:
- International Journal of Dermatology, 2022, v. 61, n. 6, p. 746, doi. 10.1111/ijd.15853
- By:
- Publication type:
- Article
Could it be gluten? Additional skin conditions associated with celiac disease.
- Published in:
- International Journal of Dermatology, 2022, v. 61, n. 1, p. 33, doi. 10.1111/ijd.15750
- By:
- Publication type:
- Article
Efalizumab for Patients With Moderate to Severe Plaque Psoriasis: A Randomized Controlled Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2003, v. 290, n. 23, p. 3073, doi. 10.1001/jama.290.23.3073
- By:
- Publication type:
- Article
Evidence that a neutrophil-keratinocyte crosstalk is an early target of IL-17A inhibition in psoriasis.
- Published in:
- Experimental Dermatology, 2015, v. 24, n. 7, p. 529, doi. 10.1111/exd.12710
- By:
- Publication type:
- Article
Efficacy and safety of risankizumab for active psoriatic arthritis: 52-week results from the KEEPsAKE 1 study.
- Published in:
- Rheumatology, 2023, v. 62, n. 6, p. 2113, doi. 10.1093/rheumatology/keac607
- By:
- Publication type:
- Article
Efficacy and safety of risankizumab for active psoriatic arthritis: 52-week results from the KEEPsAKE 2 study.
- Published in:
- Rheumatology, 2023, v. 62, n. 6, p. 2122, doi. 10.1093/rheumatology/keac605
- By:
- Publication type:
- Article
Risankizumab improved health-related quality of life, fatigue, pain and work productivity in psoriatic arthritis: results of KEEPsAKE 1.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. 629, doi. 10.1093/rheumatology/keac342
- By:
- Publication type:
- Article
Corrigendum to: Safety of ixekizumab in adult patients with plaque psoriasis, psoriatic arthritis and axial spondyloarthritis: data from 21 clinical trials.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Safety of ixekizumab in adult patients with plaque psoriasis, psoriatic arthritis and axial spondyloarthritis: data from 21 clinical trials.
- Published in:
- Rheumatology, 2020, v. 59, n. 12, p. 3834, doi. 10.1093/rheumatology/keaa189
- By:
- Publication type:
- Article
Predictors of Topical Use in Psoriasis Patients in the REFINE Study.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2016, v. 20, n. 2, p. 106, doi. 10.1177/1203475415604322
- By:
- Publication type:
- Article
A Novel Aerosol Foam Formulation of Calcipotriol and Betamethasone Has No Impact on HPA Axis and Calcium Homeostasis in Patients With Extensive Psoriasis Vulgaris.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2016, v. 20, n. 1, p. 44, doi. 10.1177/1203475415597094
- By:
- Publication type:
- Article
Long-term Management of Moderate to Severe Plaque Psoriasis Patients With Etanercept: A Case Series.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2015, v. 19, n. 6, p. 561, doi. 10.1177/1203475415584511
- By:
- Publication type:
- Article
Preparing for Subsequent Entry Biologics in Dermatology and Rheumatology in Canada.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2013, v. 17, n. 5, p. 340, doi. 10.2310/7750.2013.13006
- By:
- Publication type:
- Article
Understanding and Assessing Potential Serious Adverse Events: A Practical Approach to Understanding the Benefits and Harm of Psoriasis Treatments.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2013, v. 17, n. 3, p. 189, doi. 10.2310/7750.2012.12046
- By:
- Publication type:
- Article
Examining the Risk of Cardiovascular Disease in Patients with Psoriasis: A Critical Review.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2013, v. 17, n. 2, p. 89, doi. 10.2310/7750.2012.11126
- By:
- Publication type:
- Article
Biologic Therapy in Psoriasis: Perspectives on Associated Risks and Patient Management.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2012, v. 16, n. 3, p. 153, doi. 10.1177/120347541201600305
- By:
- Publication type:
- Article
Topical Psoriasis Therapy in the Age of Biologics: Evidence-Based Treatment Recommendations.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2011, v. 15, n. 6, p. 309, doi. 10.2310/7750.2011.10080
- By:
- Publication type:
- Article
Canadian Guidelines for the Management of Plaque Psoriasis: Overview.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2011, v. 15, n. 4, p. 210, doi. 10.2310/7750.2011.10066
- By:
- Publication type:
- Article
Epidemiology of Moderate-to-Severe Plaque Psoriasis in a Canadian Surveyed Population.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2010, v. 14, n. 4, p. 167, doi. 10.2310/7750.2010.09066
- By:
- Publication type:
- Article
Psoriasis Care: New and Emerging Pharmacologic Trends.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2010, v. 14, n. 3, p. 119, doi. 10.2310/7750.2010.09039
- By:
- Publication type:
- Article
Update on Alefacept Safety.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2009, v. 13, n. S3, p. S139, doi. 10.2310/7750.2009.00032
- By:
- Publication type:
- Article
Patterns of Combination Therapy with Alefacept for the Treatment of Psoriasis in Canada in the AWARE Study.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2009, v. 13, n. S3, p. S131, doi. 10.2310/7750.2009.00031
- By:
- Publication type:
- Article
The AWARE Study: Methodology and Baseline Characteristics.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2009, v. 13, n. S3, p. S113, doi. 10.2310/7750.2009.00029
- By:
- Publication type:
- Article
Update on Alefacept Safety.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2009, v. 13, p. S139, doi. 10.2310/7750.2009.00032
- By:
- Publication type:
- Article
Patterns of Combination Therapy with Alefacept for the Treatment of Psoriasis in Canada in the AWARE Study.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2009, v. 13, p. S131, doi. 10.2310/7750.2009.00031
- By:
- Publication type:
- Article
The AWARE Study: Methodology and Baseline Characteristics.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2009, v. 13, p. S113, doi. 10.2310/7750.2009.00029
- By:
- Publication type:
- Article
A Canadian Self-Administered Online Survey to Evaluate the Impact of Moderate-to-Severe Psoriasis among Patients.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2009, v. 13, n. 6, p. 294, doi. 10.2310/7750.2009.08066
- By:
- Publication type:
- Article
Adalimumab in the Treatment of Psoriasis: Pooled Efficacy and Safety Results from Three Pivotal Studies.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2009, v. 13, p. S58, doi. 10.2310/7750.2009.00022
- By:
- Publication type:
- Article
Targeting the Interleukin-12/23 Cytokine Family in the Treatment of Psoriatic Disease.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2008, p. S1, doi. 10.2310/7750.2008/08070
- By:
- Publication type:
- Article
Long-Term Safety of Etanercept.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2007, v. 11, p. S23, doi. 10.2310/7750.2006.00071
- By:
- Publication type:
- Article
Mechanism of Action, Pharmacokinetics, and Drug Interactions of Etanercept in Dermatology.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2007, v. 11, p. S1, doi. 10.2310/7750.2006.00069
- By:
- Publication type:
- Article
Etanercept: A Novel Tumor Necrosis Factor Antagonist for the Treatment of Psoriatic Disease.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2007, v. 11, p. S1, doi. 10.2310/7750.2006.00068
- By:
- Publication type:
- Article
Long-Term Safety of Etanercept.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2007, v. 11, p. S23, doi. 10.2310/7750.2006.00071
- By:
- Publication type:
- Article
Mechanism of Action, Pharmacokinetics, and Drug Interactions of Etanercept in Dermatology.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2007, v. 11, p. S3, doi. 10.2310/7750.2006.00069
- By:
- Publication type:
- Article
Etanercept: A Novel Tumor Necrosis Factor Antagonist for the Treatment of Psoriatic Disease.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2007, v. 11, p. S1, doi. 10.2310/7750.2006.00068
- By:
- Publication type:
- Article
Efalizumab for the Treatment of Psoriatic Arthritis.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2007, v. 11, n. 2, p. 57, doi. 10.2310/7750.2007.00006
- By:
- Publication type:
- Article
Clinical Efficacy of Efalizumab in Patients With Chronic Plaque Psoriasis: Results From Three Randomized Placebo-Controlled Phase III Trials: Part I.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2005, v. 9, n. 6, p. 303, doi. 10.1007/s10227-005-0116-1
- By:
- Publication type:
- Article
Safety of Efalizumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: Review of Clinical Data. Part II.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2005, v. 9, n. 6, p. 313, doi. 10.1007/s10227-005-0117-0
- By:
- Publication type:
- Article
Safe Psoriasis Control: A New Outcome Measure for the Composite Assessment of the Efficacy and Safety of Psoriasis Treatment.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2005, v. 9, n. 6, p. 276, doi. 10.1007/s10227-005-0121-4
- By:
- Publication type:
- Article
Strategies for optimizing treatment with efalizumab in moderate to severe psoriasis.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2005, v. 9, p. 26, doi. 10.1007/s10227-006-0104-0
- By:
- Publication type:
- Article
Recommendations for incorporating biologicals into management of moderate to severe plaque psoriasis: individualized patient approaches.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2005, v. 9, p. 18, doi. 10.1007/s10227-006-0103-1
- By:
- Publication type:
- Article
A favourable benefit/risk ratio with efalizumab: A review of the clinical evidence.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2005, v. 9, p. 10, doi. 10.1007/s10227-006-0102-2
- By:
- Publication type:
- Article
Integrating Biologic Agents into Management of Moderate-to-Severe Psoriasis: A Consensus of the Canadian Psoriasis Expert Panel.
- Published in:
- Journal of Cutaneous Medicine & Surgery, 2004, v. 8, n. 5, p. 321, doi. 10.1007/s10227-005-0035-1
- By:
- Publication type:
- Article
Safety and Immunogenicity of Inactivated Varicella-Zoster Virus Vaccine in Adults With Autoimmune Disease: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
- Published in:
- Clinical Infectious Diseases, 2017, v. 65, n. 7, p. 1174, doi. 10.1093/cid/cix484
- By:
- Publication type:
- Article
Evaluating practice patterns for managing moderate to severe plaque psoriasis: role of the family physician.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Immunosuppressive therapy in dermatology and PML.
- Published in:
- 2009
- By:
- Publication type:
- Editorial